Skip to main content

Table 1 Characterization of asthmatic children compared to non-asthma control subjects

From: Polycyclic aromatic hydrocarbon exposure and pediatric asthma in children: a case–control study

Parameters Control Asthma P value
Age (years) 13.5 ± 4.2 13.7 ± 2.9 0.81
BMI (kg/m2) 21.1 ± 5.5 21.3 ± 6.6 0.81
Waist circumference (cm) 66.6 ± 15.1 70.7 ± 17.1 0.09
Hip circumference (cm) 82.1 ± 20.7 83.8 ± 19.9 0.54
SAD (cm) 17.0 ± 7.5 17.7 ± 19.6 0.53
Cholesterol (mmol/l) 4.3 ± 0.88 4.1 ± 0.72 0.07
Glucose (mmol/l) 5.3 ± 1.7 5.3 ± 1.7 0.90
HDL-Cholesterol (mmol/l) 1.04 ± 0.34 0.90 ± 0.31 0.008
Triglycerides (mmol/l) 1.1 ± 0.60 1.03 ± 0.41 0.59
LDL-Cholesterol (mmol/l) 2.8 ± 0.80 2.7 ± 0.67 0.21
IgE (pg/ml) 61.1 ± 4.3 123.1 ± 5.0 0.004
Resistin (pg/ml) 17.3 ± 1.3 24.5 ± 1.6 <0.001
GMCSF (pg/ml) 1.9 ± 0.10 1.0 ± 0.11 0.003
INF-gamma (pg/ml) 2.4 ± 0.74 1.6 ± 0.63 0.03
IL4 (pg/ml) 9.2 ± 1.4 18.5 ± 3.6 0.003
IL5 (pg/ml) 0.92 ± 0.20 0.52 ± 0.17 <0.001
IL8 (pg/ml) 12.4 ± 1.8 6.3 ± 1.2 0.004
IL10 (pg/ml) 12.1 ± 1.7 9.2 ± 1.4 0.03
Naphthalene (ng/ml) 10.7 ± 2.7 26.2 ± 2.5 <0.001
Anthracene (ng/ml) 239.5 ± 22.6 260.1 ± 52.3 0.79
Fluorene (ng/ml) 2.5 ± 0.75 3.6 ± 0.90 0.04
Phenanthrene (ng/ml) 9.3 ± 1.7 11.5 ± 1.9 0.13
4H-cyclobenta[def]phenanthrene (ng/ml) 6.2 ± 1.1 20.3 ± 2.1 <0.001
Pyrene (ng/ml) 0.67 ± 0.34 1.1 ± 0.50 0.04
Flouranthene (ng/ml) 26.9 ± 3.2 31.8 ± 3.4 0.60
1,2-benzanthracene (ng/ml) 0.37 ± 0.24 0.73 ± 0.36 0.01
Chrysene (ng/ml) 0.87 ± 0.19 1.8 ± 0.13 0.001
Benzo(e)pyrene (ng/ml) 1.6 ± 0.17 2.6 ± 0.20 0.32
Benzoacephenanthrylene (ng/ml) 1.7 ± 0.23 7.0 ± 0.90 0.006
Benzo(a)pyrene (ng/ml) 2.1 ± 0.80 4.8 ± 0.93 0.02